Bank of America’s Anbio Biotechnology NNNN Stock Holding History

Bank of America’s Portfolio NNNN Stock Details NNNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-21	Closed	-$782	–	8537
2025 Q3	$782	Buy	+21	New	+$943	﹤0.01%	7525

Other funds holding NNNN

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America's NNNN Position: Q4 2025 in Review

Bank of America sold out of Anbio Biotechnology (NNNN) in Q4 2025, closing a stake of 21 shares — an estimated $782 sold.

Bank of America first reported a position in NNNN in Q3 2025 and held it in 1 quarter. The position peaked at $782 in Q3 2025. 5 funds tracked by Wall St. Rank hold NNNN as of Q4 2025.

Bank of America reported no remaining Anbio Biotechnology position as of Q4 2025 after selling out during the quarter.
Bank of America sold 21 Anbio Biotechnology shares in Q4 2025, an estimated $782.
Bank of America first reported a position in Anbio Biotechnology in Q3 2025 and held it in 1 quarter.
Bank of America's Anbio Biotechnology position peaked at $782 in Q3 2025.
5 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.